Stanford Hospital & Clinics (SHC)is world-renowned for advanced patient care, particularly for the treatment of cancer. It is recognized by U.S. News & World Report as one of “America’s Best Hospitals” and currently ranked #10th in the U.S for cancer. SHC is also a National Cancer Institute (NCI) Designated Cancer Center. Stanford Hospital & Clinics has a close relationship with both the Stanford University School of Medicine and Lucile Packard Children’s Hospital, an adjacent pediatric teaching hospital providing general acute and tertiary care. The hospital is located on the Stanford University campus in Palo Alto, California; it is about 20 miles north of San Jose and about 40 miles south of San Francisco.
Clinical pharmacists at Stanford Hospital & Clinics cover all acute patient care areas and select ambulatory care clinics.
The Hematology/Oncology Residency at Stanford Hospital & Clinics is a PGY-2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center, currently ranked top 10 in the nation. One applicant is accepted per year.
The program is designed to transition PGY-1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and/or hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming responsibility for pharmaceutical care.
Throughout the program, the resident will gain practical experience in the management in neoplastic diseases as well as cancer-related and cancer treatment-related disorders. Due to the prominent use of investigational drugs in the treatment of cancer, the resident will also gain the knowledge and skills necessary to practice effectively in clinical research environments. They will be able to manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Their experience will also include leadership in formulary decision-making for cancer-related medications.
Groomed for practice leadership, the PGY-2 Hematology/Oncology resident will be able to successfully serve health-care organizations with the clinical and practice skills necessary for effective decision-making in the treatment of oncologic and hematologic disorders..
The goal of the PGY-2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, to develop his/her clinical skills, and to prepare for a comprehensive clinical practice in hematology/oncology.
The Hematology/Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.
- Orientation/Training – 1-2 weeks
- Inpatient Oncology – 4-6 weeks
- Inpatient Hematology – 4-6 weeks
- Inpatient Blood and Marrow Transplantation (BMT) – 4 weeks
- Outpatient Hematology/Oncology/BMT Clinics – 12 weeks and longitudinal
- Research Project – longitudinal
- Chemotherapy Preparation and Dispensing – longitudinal
- Pediatric Hematology/Oncology/BMT
- Off-site Hematology/Oncology/BMT Services*
- Inpatient Infectious Disease
- Palliative/Hospice Care
- Pain Service
- Hematology Consults
- Oncology Consults
* A maximum of one off-site rotation will be permitted.
- Complete and present a research project at the Western States Conference and/or HOPA annual meeting.
- Participate in teaching activities with PGY1 residents and pharmacy students
- Prepare and present drug monograph for the Pharmacy & Therapeutics Committee
- Staff 16 hours every 4 weeks
- Attend hematology/oncology related committee meetings and teaching sessions
Alice Chang, Pharm.D. received her degree from the University of Colorado in 1998. She completed an ambulatory care residency at University of Illinois at Chicago and worked at Olive-View UCLA Medical Center for 4 years before joining Stanford Hospital and Clinics in 2003. She is currently practicing as a clinical oncology pharmacist in the outpatient Cancer Center.
Ya-Hwei Cheng, MS, Pharm.D. (Bone Marrow Transplant) received her MS in health system management from Union University, NY and pharmacy degree. from University of Florida. She joined Stanford Hospital and Clinics in 1997. She has practiced in medicine, critical care, cardiology, orthopedics, pediatrics, oncology and investigational drug services. She is currently a clinical pharmacist specializing in BMT.
Magdalena Cudny, Pharm.D., BCPS received her degree from the University of California, San Francisco in 2006. She completed a pharmacy practice residency at Stanford Hospital and Clinics. She worked as a clinical pharmacist for 2 years before transitioning into hematology and oncology at Stanford Hospital and Clinics.
Latanya Dean, Pharm.D. (Lead Pharmacist) received her degree from the University of Washington in 2001. She completed a general practice residency at Stanford Hospital and Clinics in June 2002. After residency she accepted a clinical position at SHC and currently works in the Cancer Center as a Lead Pharmacist overseeing the inpatient and outpatient oncology pharmacy services.
Michelle Ho, Pharm.D., BCOP received her degree from University of the Pacific in 2008. She completed her pharmacy practice residency and PGY2 hematology/oncology pharmacy residency at Stanford Hospital and Clinics. Upon the completion of her PGY2 residency in 2010, she accepted a position at SHC as a clinical pharmacist specializing in hematology and oncology.
Ann Le, Pharm.D., BCPS received her degree from the University of California, San Francisco in 2009. She completed a pharmacy practice residency at University of California, San Diego. She completed a hematology/oncology residency at Stanford Hospital and Clinics in 2010 and currently works as a clinical pharmacist in the inpatient hematology/oncology area.
Fu-ying Lee-Lam, R.Ph. received her B.S from St. John’s University, New York in 1988. She worked at Memorial Sloan Kettering for five years before moving to California. Currently she works at Stanford Hospital and Clinics as a Bone Marrow Transplant pharmacist. BMT has been her focus of practice for the last 15 years.
Dat Ngo, Pharm.D. received his degree from the University of Southern California in 2010. He completed a PGY-1 Pharmacy Practice Residency at Kaiser Permanente Tri-Central (Baldwin Park-Downey-South Bay) and his PGY-2 Hematology/Oncology Residency at Stanford Hospital & Clinics. He currently works as a clinical pharmacist in the inpatient and outpatient hematology/oncology settings.
Samit Patel, Pharm.D., BCOP graduated from the University of Houston in 2007. He completed his pharmacy practice residency at Presbyterian Hospital of Dallas/Texas Tech University Health Science Center. He completed a hematology/oncology residency at Stanford Hospital and Clinics and currently works as a clinical pharmacist in hematology/oncology.
Faye Tsung, Pharm.D. received her Bachelors in Pharmacy at University of Toronto in 1989. In 1990, she completed an Industrial Pharmacy Residency at Eli Lilly Canada Inc. In 1994 she received her Doctor of Pharmacy degree at Philadelphia College of Pharmacy and Science. The following year she completed an oncology residency at University of Illinois at Chicago. She joined Stanford Hospital and Clinics in 2002 and currently works as a BMT/Oncology pharmacist.
Ann Vongspanich, Pharm.D. received her BS degree in Biology at Santa Clara University then obtained her pharmacy degree at University of the Pacific. She completed her pharmacy practice residency at Stanford Hospital and Clinics in 2005. She currently works in the ambulatory care anticoagulation clinic and cancer center pharmacy.
Joanna Wang, Pharm.D. received her undergraduate degree in Biology from the University of California, Irvine and her Doctor of Pharmacy degree from the University of Southern California in 1991. She completed her residency at University of California, Los Angeles in 1992 and currently works as a clinical pharmacist in Bone Marrow Transplant & Oncology.
PGY-2 residents receive a competitive annual stipend of approximately $84,000 with full benefits, including an excellent health-care benefits package and 10 days paid time off. In addition, the PGY2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.
Participation in our Hematology/Oncology Specialty Residency Program requires a Pharm.D. degree from an ACPE-accredited College or School of Pharmacy and completion of an ASHP-accredited PGY-1 residency. Out of state candidates must obtain a California Intern license prior to the first day of residency and California Pharmacist licensure must be obtained within 3 months of start date of residency.
Interested applicants must complete ALL of the following:
- Enrollment in the ASHP Residency Match Program
- Submit the following required documents through PhORCAS
- Your personal statement outlining career goals, areas of interest and reasons for applying to the residency program at Stanford Hospital & Clinics
- Your Curriculum Vitae
- Official School of Pharmacy transcript of records sent directly from the school
- Three letters of recommendation submitted directly by the recommender
- Complete the Stanford Hospital and Clinics online application process
- Access www.stanfordhospitalcareers.com
- Create an account
- Under "Search by Req #", enter "23617" and click "Start Job Search"
- Follow the instructions on the website
- Under the resume section, please attach your Curriculum Vitae
- When finished, click submit
For consideration, the online application and all supporting documentation must be received by Wednesday, January 1, 2014. Early submission is helpful.
After all application materials have been reviewed, selected applicants will be contacted for a half-day on-site interview to be conducted in January - February 2014. The date of the interview is negotiable based on candidate and interview panel schedules. The candidate is required to give a 15 minute Powerpoint presentation on any pharmacy-related topic (oncology topic preferred).
Interviews will be conducted on Friday, January 31, 2014.
Wednesday, January 1, 2014
NO applications will be accepted beyond this date.
|PGY-2 Hematology/Oncology Program Director:||Samit Patel, PharmD, BCOP|